About this webinar
Join US May 12th at 11 AM MT to discuss the emerging industry of psychedelic medicines. As psychedelics become more mainstream and the medical world recognizes their potential, how will for-profit organizations bridge the gap of ancient modalities with modern science? We'll discuss the business, investment, and economic challenges of building companies while also legitimizing an emerging industry.
For expert insights, we're honored to have Jean-Paul O’Brien, Founder of Me Biosciences and Black Lab Sports as our host. Our esteemed guests include: JR Rahn, Founder and Director of MindMed; Christian Angermayer, Founder of ATAI Life Sciences; and Seth Levine, Co-Founder of Foundry Group and Founder of Pledge 1%.
Maya is a psychedelic therapy intelligence platform, designed to bring greater trust, transparency, and measurement to the patient’s journey. The platform is geared to become the world’s largest database of psychedelic health outcomes, fueling insights to help psychedelic healthcare scale safely.
JR Rahn is the founder and Director of MindMed, a psychedelic focused startup. MindMed is assembling a compelling drug development pipeline of psychedelic inspired medicines through human clinical trials.
JP O'Brien is the founder of Black Lab Sports, a company that invests in, launches, and scales companies whose founders live their purpose and who focus on pushing the limits of Human Potential. He is also the founder and CEO of Me Biosciences, a precision nutrition company.
Seth Levine is Managing Director at Foundry Group, which invests in technology companies throughout the US and Canada. Seth is also Founder of Pledge 1%, which makes it easy for startups to support nonprofits in their community through philanthropic donations.
Christian Angermeyer is the Founder of ATAI life. ATAI is a global biotech company builder that leverages a decentralized, technology- and data-driven platform model to serve millions of people suffering from mental health disorders.
Psychedelic research nonprofit combining data and lived experiences to serve the community, educate the public, and inform common sense practices and policies.
Share this event